Upstream Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Upstream Bio
UPB Stock   31.08  0.14  0.45%   
Upstream Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Upstream Bio's valuation are provided below:
Gross Profit
2.8 M
Market Capitalization
1.3 B
Enterprise Value Revenue
467.8786
Revenue
2.8 M
Earnings Share
(6.40)
We have found one hundred twenty available fundamental trend indicators for Upstream Bio, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Upstream Bio current market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.

Upstream Bio Total Revenue

2.19 Million

Check Upstream Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Upstream Bio's main balance sheet or income statement drivers, such as Net Interest Income of 14.6 M, Interest Income of 14.6 M or Depreciation And Amortization of 57.2 K, as well as many indicators such as Price To Sales Ratio of 495, Dividend Yield of 0.0 or PTB Ratio of 1.7. Upstream financial statements analysis is a perfect complement when working with Upstream Bio Valuation or Volatility modules.
  
Build AI portfolio with Upstream Stock
Check out the analysis of Upstream Bio Correlation against competitors.
For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.

Upstream Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets581.7 M554 M116.2 M
Slightly volatile
Short and Long Term Debt Total2.2 M2.1 M436.7 K
Slightly volatile
Other Current Liabilities5.3 M6.9 M4.4 M
Slightly volatile
Total Current Liabilities8.1 M12.3 M5.9 M
Slightly volatile
Property Plant And Equipment Net2.9 M2.7 M604.4 K
Slightly volatile
Accounts Payable2.5 M4.6 M1.3 M
Slightly volatile
Cash393.5 M374.8 M78.9 M
Slightly volatile
Non Current Assets Total3.1 M2.9 M648 K
Slightly volatile
Non Currrent Assets Other234.3 K223.1 K55.1 K
Slightly volatile
Cash And Short Term Investments568.1 M541 M112.4 M
Slightly volatile
Net Receivables1.4 M1.4 M562 K
Slightly volatile
Common Stock Shares Outstanding45.5 M59 M39.1 M
Slightly volatile
Liabilities And Stockholders Equity581.7 M554 M116.2 M
Slightly volatile
Non Current Liabilities Total966.1 K1 M105.5 M
Slightly volatile
Capital Lease Obligations2.2 M2.1 M436.7 K
Slightly volatile
Other Current Assets5.6 M8.7 M2.3 M
Slightly volatile
Other Stockholder Equity797.7 M759.7 M131.7 M
Slightly volatile
Total Liabilities10.1 M10.7 M111.4 M
Slightly volatile
Property Plant And Equipment Gross3 M2.9 M644.5 K
Slightly volatile
Total Current Assets578.6 M551 M115.5 M
Slightly volatile
Capital Stock64 K61 K12.9 K
Slightly volatile
Net Working Capital565.6 M538.7 M109.3 M
Slightly volatile
Short Term Debt850.1 K809.6 K208.2 K
Slightly volatile
Common Stock64 K61 K12.9 K
Slightly volatile

Upstream Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income14.6 M13.9 M2.8 M
Slightly volatile
Interest Income14.6 M13.9 M2.8 M
Slightly volatile
Depreciation And Amortization57.2 K102.3 K23.5 K
Slightly volatile
Selling General Administrative12.6 M19.7 M8.5 M
Slightly volatile
Total Revenue2.2 M2.7 M1.5 M
Slightly volatile
Gross Profit2.2 M2.7 M1.5 M
Slightly volatile
Other Operating Expenses54.2 M92.2 M35 M
Slightly volatile
Research Development41.6 M72.4 M26.5 M
Slightly volatile
Cost Of Revenue57.2 K102.3 K23.5 K
Slightly volatile
Total Operating Expenses54.2 M92.2 M35 M
Slightly volatile
Reconciled Depreciation57.2 K102.3 K23.5 K
Slightly volatile
Total Other Income Expense Net12.7 M17.2 M3.8 M
Slightly volatile

Upstream Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation3.9 M6.9 M2.2 M
Slightly volatile
Begin Period Cash Flow18.4 M23.2 M25 M
Slightly volatile
Other Cashflows From Financing Activities104.8 M168.1 M39.9 M
Slightly volatile
Depreciation57.2 K102.3 K23.5 K
Slightly volatile
Capital Expenditures617 K587.6 K172.1 K
Slightly volatile
Issuance Of Capital Stock510.3 M486 M98.7 M
Slightly volatile
Total Cash From Financing Activities505.8 M481.7 M98 M
Slightly volatile
End Period Cash Flow393.7 M375 M79 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio495410598
Slightly volatile
Days Sales Outstanding91.2164123
Very volatile
Stock Based Compensation To Revenue1.342.281.2536
Slightly volatile
Capex To Depreciation7.286.610.2534
Slightly volatile
EV To Sales436252566
Slightly volatile
Sales General And Administrative To Revenue4.556.525.4201
Pretty Stable
Research And Ddevelopement To Revenue14.7523.9116.3944
Slightly volatile
Capex To Revenue0.20.190.0909
Slightly volatile
Cash Per Share8.668.252.0705
Slightly volatile
Income Quality0.960.850.8799
Slightly volatile
Net Debt To EBITDA3.943.751.2781
Slightly volatile
Current Ratio42.1740.1611.4073
Slightly volatile
Receivables Turnover2.192.313.2256
Pretty Stable
Capex Per Share0.00940.0090.0036
Slightly volatile
Revenue Per Share0.03870.04150.0368
Slightly volatile
Interest Debt Per Share0.03380.03210.008
Slightly volatile
Debt To Assets0.00340.00440.0046
Slightly volatile
Operating Cycle91.2164123
Very volatile
Ebt Per Ebit0.850.930.9457
Slightly volatile
Quick Ratio42.1740.1611.4073
Slightly volatile
Cash Ratio28.6827.327.9979
Slightly volatile
Cash Conversion Cycle91.2164123
Very volatile
Days Of Sales Outstanding91.2164123
Very volatile
Free Cash Flow Operating Cash Flow Ratio0.810.910.9876
Slightly volatile
Fixed Asset Turnover1.091.156.5351
Slightly volatile
Debt Ratio0.00340.00440.0046
Slightly volatile
Price Sales Ratio495410598
Slightly volatile
Asset Turnover0.00540.00570.0523
Slightly volatile

Upstream Bio Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap675.2 M759.7 M829.2 M
Slightly volatile
Enterprise Value416 M468 M510.8 M
Slightly volatile

Upstream Fundamental Market Drivers

About Upstream Bio Financial Statements

Upstream Bio stakeholders use historical fundamental indicators, such as Upstream Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Upstream Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Upstream Bio's assets and liabilities are reflected in the revenues and expenses on Upstream Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Upstream Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue2.7 M2.2 M
Cost Of Revenue102.3 K57.2 K
Stock Based Compensation To Revenue 2.28  1.34 
Sales General And Administrative To Revenue 6.52  4.55 
Research And Ddevelopement To Revenue 23.91  14.75 
Capex To Revenue 0.19  0.20 
Revenue Per Share 0.04  0.04 
Ebit Per Revenue(37.73)(39.62)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CCitigroup
SSentinelOne
When determining whether Upstream Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Upstream Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Upstream Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Upstream Bio Stock:
How To Invest In Upstream
Details
Is Upstream Stock a good investment?
Details
What is Upstream Bio's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Upstream Bio Correlation against competitors.
For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Upstream Bio. If investors know Upstream will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Upstream Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(6.40)
Revenue Per Share
0.054
Quarterly Revenue Growth
0.125
Return On Assets
(0.28)
Return On Equity
(0.41)
The market value of Upstream Bio is measured differently than its book value, which is the value of Upstream that is recorded on the company's balance sheet. Investors also form their own opinion of Upstream Bio's value that differs from its market value or its book value, called intrinsic value, which is Upstream Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Upstream Bio's market value can be influenced by many factors that don't directly affect Upstream Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Upstream Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Upstream Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Upstream Bio's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY